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A dielectrophoretic method of discrimination
between normal oral epithelium, and oral and
oropharyngeal cancer in a clinical setting
K. A. Graham,a H. J. Mulhall,a F. H. Labeed,a M. P. Lewis,b K. F. Hoettges,†a
N. Kalavrezos,c J. McCaul,d C. Liew,e S. Porter,f S. Fedelef and M. P. Hughes*a
Despite the accessibility of the oral cavity to clinical examination, delays in diagnosis of oral and
oropharyngeal carcinoma (OOPC) are observed in a large majority of patients, with negative impact on
prognosis. Diagnostic aids might help detection and improve early diagnosis, but there remains little
robust evidence supporting the use of any particular diagnostic technology at the moment. The aim of
the present feasibility first-in-human study was to evaluate the preliminary diagnostic validity of a novel
technology platform based on dielectrophoresis (DEP). DEP does not require labeling with antibodies or
stains and it is an ideal tool for rapid analysis of cell properties. Cells from OOPC/dysplasia tissue and
healthy oral mucosa were collected from 57 study participants via minimally-invasive brush biopsies and
tested with a prototype DEP platform using median membrane midpoint frequency as main analysis para-
meter. Results indicate that the current DEP platform can discriminate between brush biopsy samples
from cancerous and healthy oral tissue with a diagnostic sensitivity of 81.6% and a specificity of 81.0%.
The present ex vivo results support the potential application of DEP testing for identification of OOPC.
This result indicates that DEP has the potential to be developed into a low-cost, rapid platform as an assis-
tive tool for the early identification of oral cancer in primary care; given the rapid, minimally-invasive and
non-expensive nature of the test, dielectric characterization represents a promising platform for cost-
effective early cancer detection.
Introduction
Head and neck cancer (HNC), primarily comprising squamous
cell carcinomas of the oral cavity, oropharynx, and larynx, rep-
resents the 6th most common cancer worldwide.1 The inci-
dence of HNC is rising, mainly due to the increasing incidence
of human papilloma virus (HPV)-related oropharyngeal carci-
nomas.2 Mortality rates remain high, with current data indicat-
ing that more than half of individuals with HNC die of their
disease within five years of diagnosis.3 Most oral and
oropharyngeal carcinomas (OOPCs) are preceded by long-
standing clinical changes of the oral mucosa, mainly white
(leukoplakia) and red (erythroplakia) patches.4 Prompt identifi-
cation and histological examination of these mucosal abnorm-
alities can translate into diagnosis of early-phase OOPC, i.e. at
a stage of disease associated with favorable prognosis.4
However, early superficial OOPC is often difficult to clinically
discern from common benign oral disease, and incisional
biopsy is therefore always warranted to confirm the potentially
malignant nature of oral lesions.5 Referral to secondary care
for diagnostic incisional biopsy and subsequent histopathol-
ogy is often delayed until the disease progresses to a more
advanced, easier to detect but less curable stage, partially
accounting for the high mortality of OOPCs.4–7
Currently a significant majority of patients present with
advanced disease at diagnosis, despite the accessibility of the
oral and oropharyngeal region to clinical examination, with
relevant survival rates having remained at 20% or less over the
last 20 years.8,9 A diagnostic system that could be used in a
primary health care setting to identify early malignant disease
could potentially translate into a prompt referral, earlier diag-
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nosis and treatment of OOPC, and therefore theoretically
improve prognosis.7,10 Published studies describing the
implementation of non-invasive diagnostic aids (e.g. VELscope,
Toluidine blue, Vizilite, OralCDx Brush Test)6 have thus far
failed to demonstrate robust sensitivity and specificity in diag-
nosing OOPC, particularly early-stage disease and potentially-
malignant lesions.10–13 Ideally, an early detection system for
OOPC should consist of a non- or minimally-invasive, objec-
tive, fast, sensitive and specific, cost-effective test, conducted
in a primary care setting to identify individuals with early
disease, needing urgent referral to secondary cancer care.14
In recent years, alternating-current (AC) electrokinetic tech-
niques, such as dielectrophoresis, have been employed to
characterize and separate cells on the basis of their electro-
physiological phenotypes.15–17 Dielectrophoresis (DEP) is
observed when a polarizable particle, such as a cell, is sub-
jected to a non-uniform electric field. The cell becomes motive
under the influence of the dielectrophoretic force and is either
attracted to or repelled by regions of high electric field gradi-
ent. The direction and magnitude of cell motion is governed,
in part, by the electrophysiological properties of the cell and
the frequency of the applied voltage; cells with different electro-
physiological properties respond differently under the influ-
ence of the same range of frequencies, at the same applied
voltage.18 Therefore, electrophysiological properties of cells
can be inferred by analyzing cell motion over a range of fre-
quencies and as DEP does not require labeling with antibodies
or stains, it is an ideal tool for rapid analysis of cell properties,
particularly in cases where biomarkers are not known or are
not consistently expressed. DEP has been used in a variety of
different fields within biomedicine, including numerous
studies in cancer research. These studies have targeted a wide
range of cancers, including colon, breast and ovarian cancers,
contributing to the understanding of the mechanisms of car-
cinogenesis at a cellular level through investigation of cellular
dielectric properties.17,19–23 Specifically within the field of oral
cancer, DEP has been employed to characterize the electro-
physiological properties of in vitro human OSCC cell lines
versus immortalized keratinocyte cell lines.24–26
In this paper, we demonstrate that differences in electro-
physiological profile exist between cells collected via oral
brush biopsies (OBBs) from OOPC and healthy oral tissue. We
demonstrate that a feature of DEP spectra produced by these
OBB samples, the median midpoint frequency of the mem-
brane dispersion, offers sensitivity and specificity (when com-
paring results from OOPC and healthy OBB samples) of 80%
or greater. The aim was to demonstrate the feasibility of a
simple and minimally-invasive means of detecting OOPC
using a DEP-based system and a novel analysis parameter
which eliminated the need to measure cell radius, and hence
introduce a system of testing amenable to clinical translation.
Our results indicate that with appropriate optimization, the
DEP-based testing system presented in this paper offers a
potential low cost-per-test detection method for oral cancer,
with further potential cost reductions if samples were to be
collected remotely and processed centrally.
Materials and methods
Study cohort and sample collection
Oral brush biopsies (OBBs) sampling OOPC and healthy tissue
from the oral mucosa were collected from 57 recruited partici-
pants. OOPC OBB samples were collected from 45 consenting
patients with clinical and histopathological features of OOPC,
attending the Oral Medicine and Head and Neck Cancer
clinics of the University College London Hospital NHS Foun-
dation Trust (UCLHT) London, UK, and the Oral and Maxillo-
facial Surgery Department at Bradford Teaching Hospital,
Bradford, UK. 21 healthy control OBB samples were collected
from 12 participants (each participant providing no more than
2 samples), who were patients attending UCLHT Oral Medicine
clinics for non-mucosal disease (e.g. dental or salivary gland
disease and oro-facial pain). All experiments were performed
in compliance with the relevant laws and institutional guide-
lines. The study received favourable ethical opinion by the
National Research Ethics Service (NRES) Committee South
East Coast – Kent (reference: 12/LO/1296. Project ID: 96530).
All study participants provided written informed consent
before recruitment into the study.
All OOPC OBB samples were collected in the period
between initial diagnostic incisional biopsy and subsequent
surgical resection, therefore histopathology was used as the
gold standard for confirmation of the presence of OOPC tissue
in the OBB samples. No incisional biopsy and associated histo-
logical confirmation was obtained for healthy control samples.
The minimally-invasive Rovers® Orcellex® Brush (Rovers
Medical Devices B.V., The Netherlands) was selected for use in
this study, due to availability of supply independent of a cyto-
logical analysis package. OBB sampling was performed by
trained clinicians (SF, NK and JMcC), in accordance with the
manufacturer’s instructions for cell collection.27 The brush
head, separated from the handle, was suspended in 5–6 ml
sample storage medium, consisting of High Glucose (4.5 g
L−1) DMEM (Biosera, East Sussex, UK) supplemented with
5 mL 100 units per ml penicillin and 100 µg ml−1 streptomycin
(Sigma Aldrich, Poole, UK). Vials containing sampled speci-
mens were labeled with an anonymized alpha-numeric code,
and stored at 2–8 °C. All OBB samples were transported to the
University of Surrey, Guildford for DEP testing.
A full DEP spectrum was successfully gained for 38 OOPC
OBB samples, and 21 healthy OBB samples. 18 samples were
rejected due to poor signal-to-noise ratio leading to low R-
value in spectrum fit, caused either by insufficient cell yield
for analysis and the presence of food, bacteria and other un-
identified material within the sample.
DEP sample preparation
Prior to DEP testing, a low-conductivity iso-osmotic DEP
experimental medium was prepared, containing 17 mM dex-
trose and 248 mM sucrose in deionised water. The conduc-
tivity of this medium was then adjusted to 5 mS m−1 by
addition of iso-osmotic phosphate-buffered saline solution,
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and verified using a Jenway 470 conductivity meter (VWR
Jencons, Leicestershire, UK).
To prepare each OBB sample for DEP testing, the brush
head was agitated in the surrounding storage medium using a
vortex mixer on a low-speed setting, to dislodge any cells
adhering to the brush bristles. The brush head was removed
and the sample vial was placed in a Grant XB3 ultrasonic bath
(Grant Instruments, Cambridgeshire, UK) for 1.5 minutes, to
create a single cell solution. The resulting solution was filtered
through a nylon mesh cell strainer, of pore size 100 µm (Fisher
Scientific UK Ltd, Loughborough, UK), to remove cellular
aggregates and keratin deposits, and the filter was sub-
sequently flushed through with another 5 ml of the afore-
mentioned storage medium.
The OBB sample cell solution was then centrifuged three
times at 260g for 10 minutes; the first spin in sample storage
medium and the subsequent two spins in fresh DEP experi-
mental medium, to ensure removal of all traces of the highly-
conductive sample storage medium. Following centrifugation,
the OBB sample cell pellet was re-suspended in 200 μl of fresh
DEP experimental medium.
Cell radii were estimated for each sample by capturing
images of cells on a haemocytometer using an AVT Dolphin
F145B digital camera (Allied Vision Technologies, Germany)
mounted on a Nikon Eclipse microscope and connected to a
PC, then analysed using Image J (National Institute of Mental
Health, Maryland, US) image analysis software. The grid on a
haemocytometer was used to scale the images.
DEP-microwell experiments
DEP experiments were conducted using a prototype 3DEP
(Deptech, Uckfield, UK) DEP-Well electrode chip and reader
system, variations of which are explained in detail in prior
publications.26,28 Each DEP experiment using this system
quantified cell motion in response to application of a non-
uniform AC electric field, by measuring change in light inten-
sity distribution in the Well as a function of both time and dis-
tance (Well radius) for each frequency. The Well was divided
into ten concentric rings for analysis; the four inner rings (in
which no movement occurred during the analysis period) and
the outer ring (which was emptied of cells by both positive and
negative DEP) were not found to document cellular movement,
and were therefore excluded from analysis to reduce the
signal-to-noise ratio.
Five equally-spaced frequencies per decade (log scale) were
used over a range of 4 kHz to 20 MHz to test each OBB sample
and the DEP-Well electrode chip was energized by a 10 V
peak–peak sinusoidal signal from a Digimess FG 100 function
generator (Digimess, Reading, UK), whose output was moni-
tored using ISO-Tech IDS710 digital oscilloscope. For each fre-
quency tested, approximately 5 µl of cell solution was injected
into a Well electrode on the DEP-Well chip, which was
mounted above the light source of a Nikon Eclipse 50i upright
microscope (Nikon, Surrey, UK) and viewed at 4× magnifi-
cation. The aforementioned microscope-mounted digital
camera, captured images of the cell solution in the Well elec-
trode aperture area using Smart View for WDM software
(version 0.1.3.3, supplied with the Allied Vision Technologies
camera). Images were captured immediately prior to signal
application (i.e. at time “zero” seconds) and every three
seconds thereafter, for a period of 60 seconds. A MATLAB (the
MathWorks Inc, Nantick, MA, USA) script was then used to
assess the change in light intensity over the period that the
electric current was applied and the change in light intensity
was normalized to the image captured at time zero seconds.
After each frequency was applied, the change in light intensity
was plotted against frequency, to produce a DEP spectrum.
Prior to each frequency being tested, the DEP-well electrode
was flushed clean using fresh DEP experimental medium and
5 µl of fresh OBB cell solution was injected. These steps
ensured the results produced reflected the intrinsic frequency
response of the cells, rather than the effects of prolonged cellu-
lar exposure to electric field.
Statistical analysis
Statistical analysis of the study results was conducted using
IBM SPSS Statistics version 19.0 (SPSS Inc. Chicago, IL). Recei-
ver operating characteristic (ROC) curves were constructed to
determine which analysis conditions yielded optimum results
of sensitivity and specificity for the DEP-Well system. The
mean and associated standard error of the mean, and the nor-
mality of both the OOPC and the healthy data were determined
for each set of conditions. If both the OOPC and the healthy
data set for each combination were normally distributed, a T-
test was used to explore statistical significance. If one or both
data sets were not normally distributed, the Mann-Whitney
U test was used.
Results and discussion
Analysis of DEP spectra
Change in light intensity versus frequency plots were con-
structed for each sample tested successfully using DEP. Upon
examination of these DEP spectra, it became evident that
differences between OOPC and healthy control OBB spectra
occurred at the low frequency area of the plots, i.e. at frequen-
cies ≤1 MHz.29 This indicated that differences between OOPC
and healthy OBB samples were found at frequencies which
cannot penetrate the cells’ plasma membranes, hence the
movement of cells suspended in the DEP Well was indicative
of the electrophysiological characteristics of the cells’ plasma
membranes. Therefore, the characteristics of the membrane
regions of the resulting DEP spectra were analyzed in greater
detail. Electrophysiological spectra were obtained for exfoliated
oral cells harvested from normal and abnormal tissue.
Examples of the electrophysiological spectra of cells harvested
from normal and abnormal tissue are shown in Fig. 1.
Electrophysiological spectra for exfoliated oral cell speci-
mens were grouped and spectra within each group were aver-
aged. To average electrophysiological spectra, the light
intensity change measured for each frequency point within the
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group was averaged. A “single-shell” model was used to
approximate electrophysiological properties of cell suspen-
sions from DEP spectra. However, the model assumes a spheri-
cal morphology with a lipid bilayer surrounding the cell
interior.21,30 The morphology of keratinocytes (an example of
an exfoliated sample can be seen in Fig. 2) is heterogeneous
and dependent on cell maturation state; basal cells are spheri-
cal, prickle cells are cuboidal, granular cells are polyhedral
and cornified cells are amorphic.31 Thus, exfoliated oral cell
specimens do not comprise exclusively spherical cells. The
majority of exfoliated oral cells are harvested from the external
strata and are flat and amorphic. Depending on the site of
harvest within the oral cavity, they may be parakeratinized
(possessing a nucleus) or orthokeratinized (lacking a
nucleus).32 Furthermore, keratinized cells in keratinized epi-
thelium have a proteinacious layer deposited on the internal
and external aspects of the cell membrane.33 However, the
single-shell model was used to determine relative differences
in cell electrophysiological properties. For each electrophysio-
logical spectrum, the effective membrane capacitance value
was determined using the single-shell model.21 The mean
effective membrane capacitance of abnormal cell specimens
(3.8 ± 1.0 mF m−2) was significantly lower than the mean
effective membrane capacitance of normal cell specimens
(6.5 ± 2.6 mF m−2) (P = 0.007). The presence of significant
amounts of noise due to debris in the sample was responsible
for large error margins; furthermore, both parameters fall below
the capacitance value of ∼8 mF m−2 for a lipid bilayer, either
because the structures do not possess lipid bilayers or because
the heterogeneity of size and shapes of cells within the sample
makes conventional modelling meaningless; cell radii ranged
from approximately 9 μm for biconcave erythrocytes to approxi-
mately 55 μm for irregularly-shaped mature epithelial cells.
Classification by median membrane midpoint frequency
analysis
Although the derived capacitance value indicated the presence
of a statistically significant difference, analysis of individual
samples and the use of capacitance as a cancer biomarker (i.e.
using a capacitance value below a certain threshold as a classi-
fier for cancer in a diagnostic test) did not provide results indi-
cating that it could form the basis of an effective cancer test.
We surmised that this may have been due both to the unusual
morphology (and difficulty in generating meaningful radius
data to use in the single-shell model) raised questions regard-
ing the absolute efficacy of the model. In place of this, we
examined the possibility identifying features in the shape of
the DEP spectrum itself as a classifier. The capacitance value
is associated with the frequency of the low-frequency dis-
persion (where the polarizability rises with increasing fre-
quency), and so we examined whether the frequency at which
this occurs could itself be used as a marker; a process shown
schematically in Fig. 3.
Benguigui and Lin34 showed that the low frequency dis-
persion in Re[K(ω)]. can be approximated by the following
expression:
Re KðωÞ½  ¼ ε2  ε1
ε2 þ 2ε1 þ
3ðσ2ε1  σ1ε2Þ
τMWðσ2 þ 2σ1Þ2 1þ ω2τ2MWð Þ
ð1Þ
where ε1 and ε2 are the permittivities of the suspending
medium and cells respectively, σ1 and σ2 are the conductivities
of the suspending medium and cells respectively and τMW is
the Maxwell-Wagner relaxation time, defined as:
τMW ¼ ε2 þ ε1
σ2 þ 2σ1 ð2Þ
Eqn (1) can be rewritten and simplified to
Re KðωÞ½  ¼ Q A
1þ Cf 2
 
ð3Þ
Fig. 1 DEP spectra derived from healthy and OOPC samples, showing
the effect of a change in median membrane midpoint frequency.
Examples of electrophysiological spectra of exfoliated oral cells har-
vested from normal tissue and cancerous tissue are shown.
Fig. 2 A micrograph of a typical exfoliated sample. The scale bar rep-
resents 100 µm.
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where C = (2πτMW)2, Q is the polarizability at the high-
frequency end of the dispersion, A is change in polarizability
over the range of the dispersion. The midpoint of the tran-
sition (when Re[K(ω)] = Q − A/2) occurs when the condition in
eqn (4) is met:
C ¼ 1
f 2
A
Q Re½KðωÞ
 
 1
 
ð4Þ
Substituting known values of Q and A from the DEP spec-
trum, plus a known value on the dielectric dispersion (a value
of polarizability at a given measured frequency) allows C to be
determined, and the characteristic midpoint frequency of the
dispersion can be simply determined using
fMM ¼
ffiffiffi
1
C
r
ð5Þ
Since the observed spectra contained a degree of noise and
(unsurprisingly given the clinical nature of the samples) prone
to occasional outliers, it was important to select a method of
identifying a characteristic dispersion midpoint frequency that
is not adversely affected by outliers. Average and best-fit strat-
egies seek to find a best-fit to all data points, and as such gave
unsatisfactory results. However, median fits are less suscep-
tible to noise than means. Consequently, for each sample we
generated curves through each of the data points observed to
be in the dispersion (as opposed to at the initial or terminal
plateaus), determined the midpoint frequency associated with
each of these (typically, about five points are found in this
region) curves, and selected the median of the five midpoint
frequencies generated. The median of the membrane mid-
point frequencies is then found for each OBB sample, to give
the median membrane midpoint frequency, as shown in
Fig. 3. In order to identify the data points in this transition
region, points were assigned to the end transitions if they were
within a certain percentage of the peak value at either end of
the transition; we examined a range of band widths between
5–40% but found the optimum to be 10%, that is, samples
were then considered to be part of the dispersion if they had
values between 10–90% of the sweep of A. Analysis using this
method produced a receiver-operator characteristic (ROC)
curve (which shows the variation in sensitivity and specificity
with the variation in frequency used for sample classification)
as shown in Fig. 4. From this curve, the peak sensitivity and
specificity were identified at 81.6% and 81.0%, respectively.
When the descriptive statistics (mean ± standard error of the
mean) were analyzed, the median membrane midpoint fre-
quencies for OOPC OBB samples was found to be more than
double that for healthy OBB samples (93.41 ± 10.91 kHz vs.
42.36 ± 6.07 kHz respectively). After confirming normality
using the Kolmogorov-Smirnov test for normality, a student
T-test demonstrated clear statistically significant differences
(where p < 0.05) of p = 0.000. Although as indicated this may
not correspond to the characteristic frequency of a particular
cell types within a clearly heterogeneous sample, the effect is
sufficiently consistent for the DEP analysis of the cellular
ensemble has the potential to be used as a diagnostic marker;
Fig. 3 Schematic showing the process for determining the median membrane midpoint frequency for each DEP spectrum. Data points are
classified according to whether they are within the top and bottom plateaus (dark grey bands) or the transition between the two (white band),
according to whether they are within 10% of either end of the maximum displacement between lowest and highest value, For each point within the
transition band, a curve is fitted perfectly through the point and its midpoint frequency X is calculated. The median value of the range of midpoint
frequencies is the value selected.
Fig. 4 A Receiver-Operator Characteristic (ROC) curve for detection of
OOPC using the DEP system described in the text.
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the values of sensitivity and specificity exceed those for the
most common method of diagnosis (the conventional oral
examination), and a combination of improved sample prepa-
ration with assay optimization (such as, for example, determin-
ing different thresholds for different areas of the mouth) may
have the potential to boost this significantly.
Conclusion
Establishing minimally-invasive methods for diagnosing
OOPC is important for reducing the time to treatment and
improving long-term outcomes of affected individuals; in par-
ticular, providing information to primary care clinicians to
assist in assessing whether a patient presenting with an un-
identified lesion should be referred to specialist secondary
care for further investigation is critical in improving long-term
survival. The present study sought to establish how effectively
the DEP-Well system could distinguish between cells of oral
brush biopsies (OBB) at the extreme ends of the tissue normal-
ity scale (i.e. OOPC and healthy), and therefore evaluate the
possibility of using this system to recognize and hence diag-
nose OOPC.
This study presents a novel approach to the use of DEP for
ex vivo cell analysis. The DEP-based platform was able to dis-
tinguish between OOPC and healthy ex vivo oral epithelial
cells, sampled using oral brush biopsies, with a sensitivity of
81.6% and a specificity of 81% when classified according to
the median values of the midpoint frequencies of the low-
frequency dispersion. Furthermore, the low cost of the con-
sumables in the assay (at time of writing, this was substantially
below $10 per assay, and could be below $5 when purchased at
scale) make the test amenable to wide-scale testing in primary
care, even in relatively resource-poor areas. Furthermore, whilst
the system used here required serial measurement using a DEP-
well-based analysis platform, commercial parallel systems deve-
loped since this study was conducted would enable complete
DEP spectra to be acquired in parallel, reducing assay time to
one minute plus sample preparation. Cumulatively, these indi-
cate that DEP has the potential to form the basis of a rapid, low
cost OOPC tool for assisting clinicians when deciding whether
to refer cases of concern to secondary care.
With automated, rapid sample handling, DEP has the
potential for use at point of care; however, this work has also
shown that samples are sufficiently robust to allow mail-in to
centralized analysis laboratories, reducing the overhead costs.
In order to meet this need, improved sample preparation is
required to increase the number of biopsies producing a clini-
cally useful result; studies are being undertaken to improve this.
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